Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2022.10.061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Hanan Alkhaldi und 24 weiteren Autor:innen. Beteiligte Einrichtung: University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; Department of Medicine, University of Ma…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Hematologic Neoplasms, Graft vs Host Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Reduced intensity conditioning (RIC) regimens decrease the risk for nonrelapse mortality (NRM) in adult patients undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies but increase the risk for relapse. The aim of this study was to compare the outcomes of fludarabine-total body irradiation (TBI) with fludarabine among patients with hematologic diseases. PATIENTS AND METHODS: This retrospective study of 137 patients with different hematologic malignancies compared the outcomes of 63 patients who received a conventional RIC regimen with 2 days of IV busulfan (3.2 mg/kg/d × 2 days) and fludarabine with 74 patients who received the same regimen plus 400 cGy of fludarabine and busulfan (FB)-TBI divided in 2 doses over 1 day (200 cGy BID). Median follow-up was 4.62 years. RESULTS: The donors were either HLA-matched siblings (36%) or HLA-matched unrelated donors (64%). The FB-TBI showed trends toward improvement in progression-free survival (PFS) and overall survival (OS) over FB (5-year PFS rates 50% vs 34%, P = .06, and 5-year OS rate 53% vs 39%, P = .13). Acute graft-vs-host disease (aGVHD), relapse, and NRM were similar between the 2 groups. The 5-year cumulative incidence of chronic GVHD (cGVHD) was lower in the FB-TBI group compared with the FB group (29% vs 52%, P = .003). Multivariable analysis revealed that grade III-IV aGVHD was the only independent risk factor for worse OS (P = .001) in both groups. A high disease risk index was possibly associated with inferior OS (P = .07) in both groups. CONCLUSIONS: The FB-TBI is a safe and effective intensified RIC regimen for adult patients with hematologic malignancies. It predicted a lower risk for cGVHD and showed possibly improved PFS and OS compared with FB.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA.
- National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
- University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, USA; Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA. Electronic addres…
Zitieren
APA
Alkhaldi, H., Goloubeva, O., Rapoport, A. P., Dahiya, S., Pang, Y., Ali, M. M., Hardy, N. M., Mohindra, P., Bukhari, A., Lutfi, F., Sanchez-Petitto, G., Molitoris, J., Samanta, S., Li, X., Toth, T., Landau, M., Hodges, S., Nishioka, J., Ruehle, K., …, & Yared, J. A. (2023). Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2022.10.061
Vancouver
Alkhaldi H, Goloubeva O, Rapoport AP, Dahiya S, Pang Y, Ali MM, et al. Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2022.10.061
BibTeX
@article{Alkhaldi2023,
author = {Alkhaldi, Hanan and Goloubeva, Olga and Rapoport, Aaron P and Dahiya, Saurabh and Pang, Yifan and Ali, Moaath Mustafa and Hardy, Nancy M and Mohindra, Pranshu and Bukhari, Ali and Lutfi, Forat and Sanchez-Petitto, Gabriela and Molitoris, Jason and Samanta, Santanu and Li, Xin and Toth, Tara and Landau, Mindy and Hodges, Susan and Nishioka, Jennifer and Ruehle, Kathleen and Ridge, Linda and Gahres, Natalie and Kocoglu, Mehmet H and Atanackovic, Djordje and Malinou, Justin N and Yared, Jean A},
title = {Outcomes of Busulfan, Fludarabine, and 400 cGy Total Body Irradiation Compared With Busulfan and Fludarabine Reduced-Intensity Conditioning Regimens for Allogeneic Stem Cell Transplantation in Adult Patients With Hematologic Diseases: A Single-Center Experience},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2022.10.061}
}
EUVIMED